Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Annual Review of Plant Biology|January 27, 2017
Plant Biodiversity Change Across Scales During the AnthropoceneMark Vellend, Lander Baeten, Antoine Becker-Scarpitta, et al.World Neurosurgery|January 31, 2025
The Effect of Environmental Hypothermia on Survival in Isolated Blunt Traumatic Brain InjuryRebecca L McCune, Brit J Long, Bradley A Dengler, et al.Eclinicalmedicine|April 18, 2020
Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infectionV L McCune, M N Quraishi, S Manzoor, et al.Leukemia & Lymphoma|August 1, 2002
Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemiaSteven L McCune, Jon P Gockerman, Joseph O Moore, et al.JCO Precision Oncology|August 18, 2025
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS StudyDebu Tripathy, Joanne L Blum, Hong Zhang, et al.Proceedings. Biological Sciences|October 26, 2012
Quantifying temporal change in biodiversity: challenges and opportunitiesMaria Dornelas, Anne E Magurran, Stephen T Buckland, et al.Nature Communications|March 8, 2018
Context-dependent interactions and the regulation of species richness in freshwater fishAndrew S MacDougall, Eric Harvey, Jenny L McCune, et al.Gut|August 30, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.Journal for Immunotherapy of Cancer|October 30, 2023
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trialCaicun Zhou, Minu K Srivastava, Hao Xu, et al.Journal for Immunotherapy of Cancer|August 17, 2022
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trialKarim Fizazi, Margitta Retz, Daniel P Petrylak, et al.Pageof 5